Rapid Resolution of Atypical Hemolytic Uremic Syndrome by Eculizumab Treatment
Atypical hemolytic uremic syndrome (aHUS) is an extremely rare and life-threatening disorder. Typical HUS is often caused by Shiga toxin-positive Escherichia coli, while aHUS is caused by dysregulation of the alternative pathway of the complement system in association with genetic abnormalities or d...
Saved in:
Main Authors: | Min Seung Kim (Author), Seon Hee Lim (Author), Ji Hyun Kim (Author), Il-Soo Ha (Author), Hae Il Cheong (Author), Hee Gyung Kang (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pediatric Nephrology,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical hemolytic uremic syndrome and eculizumab therapy in children
by: Seong Heon Kim, et al.
Published: (2018) -
Life-Threatening Extrarenal Manifestations in an Infant with Atypical Hemolytic Uremic Syndrome Caused by a Complement 3-Gene Mutation
by: Sa Ra Han, et al.
Published: (2019) -
Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
by: Sara Madureira Gomes, et al.
Published: (2021) -
Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
by: Hye Jin Chang, et al.
Published: (2014) -
Meningococcal Carriage in Children with Atypical Hemolytic Uremic Syndrome Receiving Eculizumab Therapy
by: Asli Kavaz Tufan, et al.
Published: (2024)